A brief history of TOR

Biochemical Society Transactions

Volumn 39, Issue 2, 2011, Pages 437-442

  Loewith, Robbie ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Antifungal agent; Intermediary metabolism; Rapamycin; Target of rapamycin (TOR); Target of rapamycin complex (TORC); Yeast

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE; FRUCTOSE BISPHOSPHATE ALDOLASE; GLYCERALDEHYDE 3 PHOSPHATE; GLYCOGEN; GLYCOGEN PHOSPHORYLASE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PHOSPHORIBOSYL PYROPHOSPHATE; RAPAMYCIN; TARGET OF RAPAMYCIN KINASE; TETRAHYDROFOLIC ACID; TRIACYLGLYCEROL;

ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; CAENORHABDITIS ELEGANS; CARBON METABOLISM; CYTOSTASIS; DROSOPHILA MELANOGASTER; FALSE POSITIVE RESULT; GENOMICS; GLUCOSE METABOLISM; HUMAN; IMMUNOMODULATION; LIPIDOMICS; METABOLIC REGULATION; METABOLOMICS; NITROGEN METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SACCHAROMYCES CEREVISIAE; SCHIZOSACCHAROMYCES POMBE;

AMINO ACIDS; ANIMALS; HISTORY, 20TH CENTURY; HUMANS; MOLECULAR BIOLOGY; PROTEIN-SERINE-THREONINE KINASES; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SIROLIMUS; TRANSCRIPTION FACTORS;

EUKARYOTA; SACCHAROMYCES CEREVISIAE; SACCHAROMYCETALES;

EID: 79953207023     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0390437     Document Type: Review

References (81)

1. Sehgal, S.N., Baker, H. and Vezina, C. (1975) Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. J. Antibiot. (Tokyo) 28, 727-732
2. Vezina, C., Kudelski, A. and Sehgal, S.N. (1975) Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J. Antibiot. (Tokyo). 28, 721-726
3. Houchens, D.P., Ovejera, A.A., Riblet, S.M. and Slagel, D.E. (1983) Human brain tumor xenografts in nude mice as a chemotherapy model. Eur. J. Cancer Clin. Oncol. 19, 799-805
4. Thomson, A.W., Turnquist, H.R. and Raimondi, G. (2009) Immunoregulatory functions of mTOR inhibition. Nat. Rev. Immunol. 9, 324-337
5. Heitman, J., Movva, N.R. and Hall, M.N. (1991) Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253, 905-909 (Pubitemid 21917235)
6. Cafferkey, R., Young, P.R., McLaughlin, M.M., Bergsma, D.J., Koltin, Y., Sathe, G.M., Faucette, L., Eng, W.K., Johnson, R.K. and Livi, G.P. (1993) Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Mol. Cell. Biol. 13, 6012-6023
7. 1 progression. Cell 73, 585-596
8. Wullschleger, S., Loewith, R. and Hall, M.N. (2006) TOR signaling in growth and metabolism. Cell 124, 471-484
9. Shertz, C.A., Bastidas, R.J., Li, W., Heitman, J. and Cardenas, M.E. (2010) Conservation, duplication, and loss of the Tor signalling pathway in the fungal kingdom. BMC Genomics 11, 510
10. Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J.L., Bonenfant, D., Oppliger, W., Jenoe, P. and Hall, M.N. (2002) Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 10, 457-468 (Pubitemid 35284167)
11. Wedaman, K.P., Reinke, A., Anderson, S., Yates, 3rd, J., McCaffery, J.M. and Powers, T. (2003) Tor kinases are in distinct membrane-associated protein complexes in Saccharomyces cerevisiae. Mol. Biol. Cell 14, 1204-1220
12. Hara, K., Maruki, Y., Long, X., Yoshino, K., Oshiro, N., Hidayat, S., Tokunaga, C., Avruch, J. and Yonezawa, K. (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177-189
13. Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Ruegg, M.A., Hall, A. and Hall, M.N. (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122-1128
14. Kim, D.H., Sarbassov, D.D., Ali, S.M., King, J.E., Latek, R.R., Erdjument-Bromage, H., Tempst, P. and Sabatini, D.M. (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175 (Pubitemid 34876545)
15. Sarbassov, D.D., Ali, S.M., Kim, D.H., Guertin, D.A., Latek, R.R., Erdjument-Bromage, H., Tempst, P. and Sabatini, D.M. (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296-1302
16. Guertin, D.A., Stevens, D.M., Thoreen, C.C., Burds, A.A., Kalaany, N.Y., Moffat, J., Brown, M., Fitzgerald, K.J. and Sabatini, D.M. (2006) Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCα, but not S6K1. Dev. Cell 11, 859-871 (Pubitemid 44804279)
17. Jacinto, E., Facchinetti, V., Liu, D., Soto, N., Wei, S., Jung, S.Y., Huang, Q., Qin, J. and Su, B. (2006) SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127, 125-137 (Pubitemid 44466632)
18. Shiota, C., Woo, J.T., Lindner, J., Shelton, K.D. and Magnuson, M.A. (2006) Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. Dev. Cell 11, 583-589 (Pubitemid 44430900)
19. Yang, Q., Inoki, K., Ikenoue, T. and Guan, K.L. (2006) Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Genes Dev. 20, 2820-2832 (Pubitemid 44771744)
20. Fonseca, B.D., Smith, E.M., Lee, V.H., MacKintosh, C. and Proud, C.G. (2007) PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex. J. Biol. Chem. 282, 24514-24524
21. Oshiro, N., Takahashi, R., Yoshino, K., Tanimura, K., Nakashima, A., Eguchi, S., Miyamoto, T., Hara, K., Takehana, K., Avruch, J. et al. (2007) The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1. J. Biol. Chem. 282, 20329-20339
22. Pearce, L.R., Huang, X., Boudeau, J., Pawlowski, R., Wullschleger, S., Deak, M., Ibrahim, A.F., Gourlay, R., Magnuson, M.A. and Alessi, D.R. (2007) Identification of Protor as a novel Rictor-binding component of mTOR complex-2. Biochem. J. 405, 513-522 (Pubitemid 47172049)
23. Peterson, T.R., Laplante, M., Thoreen, C.C., Sancak, Y., Kang, S.A., Kuehl, W.M., Gray, N.S. and Sabatini, D.M. (2009) DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 137, 873-886
24. Sancak, Y., Thoreen, C.C., Peterson, T.R., Lindquist, R.A., Kang, S.A., Spooner, E., Carr, S.A. and Sabatini, D.M. (2007) PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol. Cell 25, 903-915 (Pubitemid 46436534)
25. Thedieck, K., Polak, P., Kim, M.L., Molle, K.D., Cohen, A., Jeno, P., Arrieumerlou, C. and Hall, M.N. (2007) PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis. PLoS ONE 2, e1217
26. Vander Haar, E., Lee, S.I., Bandhakavi, S., Griffin, T.J. and Kim, D.H. (2007) Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat. Cell Biol. 9, 316-323
27. Wang, L., Harris, T.E., Roth, R.A. and Lawrence, Jr, J.C. (2007) PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. J. Biol. Chem. 282, 20036-20044
28. Frias, M.A., Thoreen, C.C., Jaffe, J.D., Schroder, W., Sculley, T., Carr, S.A. and Sabatini, D.M. (2006) mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr. Biol. 16, 1865-1870
29. 1 progression in yeast. Mol. Biol. Cell 7, 25-42
30. Colombani, J., Raisin, S., Pantalacci, S., Radimerski, T., Montagne, J. and Leopold, P. (2003) A nutrient sensor mechanism controls Drosophila growth. Cell 114, 739-749 (Pubitemid 37186768)
31. Patel, A., Fondrk, M.K., Kaftanoglu, O., Emore, C., Hunt, G., Frederick, K. and Amdam, G.V. (2007) The making of a queen: TOR pathway is a key player in diphenic caste development. PLoS ONE 2, e509
32. Bodine, S.C., Stitt, T.N., Gonzalez, M., Kline, W.O., Stover, G.L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J.C., Glass, D.J. and Yancopoulos, G.D. (2001) Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 3, 1014-1019
33. Hoeffer, C.A. and Klann, E. (2009) mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 33, 67-75
34. Kubli, E. (2010) Sexual behavior: dietary food switch induced by sex. Curr. Biol. 20, R474-R476
35. Cryan, J.F. and O'Leary, O.F. (2010) A glutamate pathway to faster-acting antidepressants? Science 329, 913-914
36. Inoki, K., Corradetti, M.N. and Guan, K.L. (2005) Dysregulation of the TSC-mTOR pathway in human disease. Nat. Genet. 37, 19-24
37. Kapahi, P., Chen, D., Rogers, A.N., Katewa, S.D., Li, P.W., Thomas, E.L. and Kockel, L. (2010) With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. Cell Metab. 11, 453-465
38. Cybulski, N. and Hall, M.N. (2009) TOR complex 2: a signaling pathway of its own. Trends Biochem. Sci. 34, 620-627
39. Cai, H., Das, S., Kamimura, Y., Long, Y., Parent, C.A. and Devreotes, P.N. (2010) Ras-mediated activation of the TORC2-PKB pathway is critical for chemotaxis. J. Cell Biol. 190, 233-245
40. Charest, P.G., Shen, Z., Lakoduk, A., Sasaki, A.T., Briggs, S.P. and Firtel, R.A. (2010) A Ras signaling complex controls the RasC-TORC2 pathway and directed cell migration. Dev. Cell 18, 737-749
41. Wang, Y., Weiss, L.M. and Orlofsky, A. (2010) Coordinate control of host centrosome position, organelle distribution, and migratory response by Toxoplasma gondii via host mTORC2. J. Biol. Chem. 285, 15611-15618
42. Aronova, S., Wedaman, K., Aronov, P.A., Fontes, K., Ramos, K., Hammock, B.D. and Powers, T. (2008) Regulation of ceramide biosynthesis by TOR complex 2. Cell Metab. 7, 148-158
43. Jones, K.T., Greer, E.R., Pearce, D. and Ashrafi, K. (2009) Rictor/TORC2 regulates Caenorhabditis elegans fat storage, body size, and development through sgk-1. PLoS Biol. 7, e60
44. Soukas, A.A., Kane, E.A., Carr, C.E., Melo, J.A. and Ruvkun, G. (2009) Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans. Genes Dev. 23, 496-511
45. Koike-Kumagai, M., Yasunaga, K., Morikawa, R., Kanamori, T. and Emoto, K. (2009) The target of rapamycin complex 2 controls dendritic tiling of Drosophila sensory neurons through the Tricornered kinase signalling pathway. EMBO J. 28, 3879-3892
46. Shiozaki, K. (2009) Nutrition-minded cell cycle. Sci. Signaling 2, pe74
47. Huber, A., Bodenmiller, B., Uotila, A., Stahl, M., Wanka, S., Gerrits, B., Aebersold, R. and Loewith, R. (2009) Characterization of the rapamycin-sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis. Genes Dev. 23, 1929-1943
48. Soulard, A., Cremonesi, A., Moes, S., Schutz, F., Jeno, P. and Hall, M.N. (2010) The rapamycin-sensitive phosphoproteome reveals that TOR controls protein kinase A toward some but not all substrates. Mol. Biol. Cell 21, 3475-3486
49. De Virgilio, C. and Loewith, R. (2006) Cell growth control: little eukaryotes make big contributions. Oncogene 25, 6392-6415 (Pubitemid 44582284)
50. Loewith, R. (2010) TORC1 signaling in budding yeast. Enzymes 27, 147-176
51. Hardwick, J.S., Kuruvilla, F.G., Tong, J.K., Shamji, A.F. and Schreiber, S.L. (1999) Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins. Proc. Natl. Acad. Sci. U.S.A. 96, 14866-14870
52. Peng, T., Golub, T.R. and Sabatini, D.M. (2002) The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Mol. Cell. Biol. 22, 5575-5584
53. Duvel, K., Yecies, J.L., Menon, S., Raman, P., Lipovsky, A.I., Souza, A.L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S. et al. (2010) Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 39, 171-183
54. Gancedo, J.M. (1998) Yeast carbon catabolite repression. Microbiol. Mol. Biol. Rev. 62, 334-361
55. Diaz-Ruiz, R., Uribe-Carvajal, S., Devin, A. and Rigoulet, M. (2009) Tumor cell energy metabolism and its common features with yeast metabolism. Biochim. Biophys. Acta 1796, 252-265
56. Barcena, M., Radermacher, M., Bar, J., Kopperschlager, G. and Ruiz, T. (2007) The structure of the ATP-bound state of S. cerevisiae phosphofructokinase determined by cryo-electron microscopy. J. Struct. Biol. 159, 135-143
57. Sols, A. (1981) Multimodulation of enzyme activity. Curr. Top. Cell Regul. 19, 77-101
58. Rodicio, R., Strauss, A. and Heinisch, J.J. (2000) Single point mutations in either gene encoding the subunits of the heterooctameric yeast phosphofructokinase abolish allosteric inhibition by ATP. J. Biol. Chem. 275, 40952-40960
59. Schwelberger, H.G., Kohlwein, S.D. and Paltauf, F. (1989) Molecular cloning, primary structure and disruption of the structural gene of aldolase from Saccharomyces cerevisiae. Eur. J. Biochem. 180, 301-308
60. Jimenez, A., Santos, M.A. and Revuelta, J.L. (2008) Phosphoribosyl pyrophosphate synthetase activity affects growth and riboflavin production in Ashbya gossypii. BMC Biotechnol. 8, 67
61. Becker, M.A., Smith, P.R., Taylor, W., Mustafi, R. and Switzer, R.L. (1995) The genetic and functional basis of purine nucleotide feedback-resistant phosphoribosylpyrophosphate synthetase superactivity. J. Clin. Invest. 96, 2133-2141
62. de Brouwer, A.P., Williams, K.L., Duley, J.A., van Kuilenburg, A.B., Nabuurs, S.B., Egmont-Petersen, M., Lugtenberg, D., Zoetekouw, L., Banning, M.J., Roeffen, M. et al. (2007) Arts syndrome is caused by loss-of-function mutations in PRPS1. Am. J. Hum. Genet. 81, 507-518
63. Kim, H.J., Sohn, K.M., Shy, M.E., Krajewski, K.M., Hwang, M., Park, J.H., Jang, S.Y., Won, H.H., Choi, B.O., Hong, S.H. et al. (2007) Mutations in PRPS1, which encodes the phosphoribosyl pyrophosphate synthetase enzyme critical for nucleotide biosynthesis, cause hereditary peripheral neuropathy with hearing loss and optic neuropathy (cmtx5). Am. J. Hum. Genet. 81, 552-558
64. Hernando, Y., Carter, A.T., Parr, A., Hove-Jensen, B. and Schweizer, M. (1999) Genetic analysis and enzyme activity suggest the existence of more than one minimal functional unit capable of synthesizing phosphoribosyl pyrophosphate in Saccharomyces cerevisiae. J. Biol. Chem. 274, 12480-12487
65. Miller, S.M. and Magasanik, B. (1990) Role of NAD-linked glutamate dehydrogenase in nitrogen metabolism in Saccharomyces cerevisiae. J. Bacteriol. 172, 4927-4935 (Pubitemid 20281938)
66. Breitkreutz, A., Choi, H., Sharom, J.R., Boucher, L., Neduva, V., Larsen, B., Lin, Z.Y. Breitkeutz, B.J., Stark, C., Liu, G. et al. (2010) A global protein kinase and phosphatase interaction network in yeast. Science 328 1043-1046
67. Uno, I., Matsumoto, K., Adachi, K. and Ishikawa, T. (1984) Regulation of NAD-dependent glutamate dehydrogenase by protein kinases in Saccharomyces cerevisiae. J. Biol. Chem. 259, 1288-1293
68. Walther, T., Novo, M., Rossger, K., Letisse, F., Loret, M.O., Portais, J.C. and Francois, J.M. (2010) Control of ATP homeostasis during the respiro-fermentative transition in yeast. Mol. Syst. Biol. 6, 344
69. Fischer, H., Esbjornsson, M., Sabina, R.L., Stromberg, A., Peyrard-Janvid, M. and Norman, B. (2007) AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects. J. Appl. Physiol. 103, 315-322
70. Kern, L. (1990) The U.K. gene of Saccharomyces cerevisiae encoding uridine kinase. Nucleic Acids Res. 18, 5279
71. Kurtz, J.E., Exinger, F., Erbs, P. and Jund, R. (1999) New insights into the pyrimidine salvage pathway of Saccharomyces cerevisiae: requirement of six genes for cytidine metabolism. Curr. Genet. 36, 130-136
72. Guldener, U., Koehler, G.J., Haussmann, C., Bacher, A., Kricke, J., Becher, D. and Hegemann, J.H. (2004) Characterization of the Saccharomyces cerevisiae Fol1 protein: starvation for C1 carrier induces pseudohyphal growth. Mol. Biol. Cell 15, 3811-3828
73. Parrou, J.L., Enjalbert, B., Plourde, L., Bauche, A., Gonzalez, B. and Francois, J. (1999) Dynamic responses of reserve carbohydrate metabolism under carbon and nitrogen limitations in Saccharomyces cerevisiae. Yeast 15, 191-203 (Pubitemid 29083955)
74. Koffel, R., Tiwari, R., Falquet, L. and Schneiter, R. (2005) The Saccharomyces cerevisiae YLL012/YEH1, YLR020/YEH2, and TGL1 genes encode a novel family of membrane-anchored lipases that are required for steryl ester hydrolysis. Mol. Cell. Biol. 25, 1655-1668
75. Rajakumari, S. and Daum, G. (2010) Janus-faced enzymes yeast Tgl3p and Tgl5p catalyze lipase and acyltransferase reactions. Mol. Biol. Cell 21, 501-510
76. Gancedo, C. and Flores, C.L. (2004) The importance of a functional trehalose biosynthetic pathway for the life of yeasts and fungi. FEMS Yeast Res. 4, 351-359 (Pubitemid 38156199)
77. 0. Mol. Cell 12, 1607-1613
78. Buscher, J.M., Czernik, D., Ewald, J.C., Sauer, U. and Zamboni, N. (2009) Cross-platform comparison of methods for quantitative metabolomics of primary metabolism. Anal. Chem. 81, 2135-2143
79. Warburg, O. (1956) On the origin of cancer cells. Science 123, 309-314
80. Wellen, K.E. and Thompson, C.B. (2010) Cellular metabolic stress: considering how cells respond to nutrient excess. Mol. Cell 40, 323-332
81. Allen-Auerbach, M. and Weber, W.A. (2009) Measuring response with FDG-PET: methodological aspects. Oncologist 14, 369-377